Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thrombopoietin mRNA (TPO mRNA)
- Target
- TPO mRNA
- Molecular classification
- Oligonucleotide, messenger RNA, Cytokine transcript
01
Overview
Thrombopoietin mRNA is the transcript of the *THPO* gene, encoding thrombopoietin—a protein hormone essential for platelet production. The mRNA is constitutively expressed in the liver and kidney and regulates platelet production through translation of the encoded protein in response to hematological demand[1][3][8]. Recent advances have enabled therapeutic use of synthetic TPO mRNA delivered by lipid nanoparticles, raising plasma TPO and increasing platelet counts in animal models of thrombocytopenia, thereby establishing this molecule as a viable and potentially safe target in synthetic mRNA-based therapies[2].
- Other names
- TPO mRNAThrombopoietin transcriptTHPO mRNA
02
Mechanism of action
mRNA-based therapy: Delivered TPO mRNA is translated to functional thrombopoietin protein, which subsequently binds to the thrombopoietin receptor on hematopoietic cells, triggering signaling pathways for platelet and megakaryocyte expansion
03
Biological functions
Encodes thrombopoietin proteinRegulates megakaryocyte differentiation and platelet productionStimulates hematopoiesis
04
Disease associations
ThrombocytopeniaAmegakaryocytic thrombocytopeniaOther hematological disorders related to platelet production
05
Safety considerations
Potential for excessive platelet counts (thrombocytosis)Unintended immunogenicity or cytokine-like effects due to exogenous mRNAGeneral safety uncertainties related to synthetic mRNA therapeutics (e.g., risk of off-target effects, delivery system toxicity)
06
Interacting drugs
Synthetic/chemically modified thrombopoietin mRNA
07
Biomarkers
Platelet countCirculating thrombopoietin protein levels
Beyond the preview
Go deeper on Thrombopoietin mRNA (TPO mRNA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thrombopoietin mRNA (TPO mRNA).